Jacques Joubert

1.5k total citations
63 papers, 1.1k citations indexed

About

Jacques Joubert is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Jacques Joubert has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Organic Chemistry and 16 papers in Pharmacology. Recurrent topics in Jacques Joubert's work include Cholinesterase and Neurodegenerative Diseases (16 papers), Pharmacological Receptor Mechanisms and Effects (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (9 papers). Jacques Joubert is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (16 papers), Pharmacological Receptor Mechanisms and Effects (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (9 papers). Jacques Joubert collaborates with scholars based in South Africa, United States and Egypt. Jacques Joubert's co-authors include Sarel F. Malan, Douglas W. Oliver, Ali A. El‐Emam, Rajan Sharma, Okobi E. Ekpo, Sylvester I. Omoruyi, Olivier Blacque, Nora Hamad Al‐Shaalan, Lamya H. Al-Wahaibi and Ivan R. Green and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Jacques Joubert

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Joubert South Africa 20 611 368 292 184 97 63 1.1k
Salvatore Guccione Italy 23 677 1.1× 599 1.6× 209 0.7× 180 1.0× 73 0.8× 73 1.5k
Lesetja J. Legoabe South Africa 19 601 1.0× 338 0.9× 291 1.0× 117 0.6× 42 0.4× 79 1.1k
Angela Stefanachi Italy 23 834 1.4× 578 1.6× 510 1.7× 325 1.8× 77 0.8× 55 1.8k
Chandra Bhushan Mishra India 22 761 1.2× 663 1.8× 377 1.3× 247 1.3× 81 0.8× 49 1.3k
Modesto de Candia Italy 19 399 0.7× 273 0.7× 315 1.1× 216 1.2× 73 0.8× 63 885
Paul C. Trippier United States 21 827 1.4× 802 2.2× 224 0.8× 116 0.6× 181 1.9× 55 1.8k
Bruno Catalanotti Italy 21 415 0.7× 573 1.6× 336 1.2× 292 1.6× 69 0.7× 59 1.4k
Nasimul Hoda India 21 646 1.1× 508 1.4× 498 1.7× 375 2.0× 232 2.4× 47 1.5k
Hiroshi Kogen Japan 24 809 1.3× 502 1.4× 398 1.4× 170 0.9× 141 1.5× 76 1.4k
Shikha Kumari India 21 910 1.5× 598 1.6× 303 1.0× 209 1.1× 57 0.6× 43 1.4k

Countries citing papers authored by Jacques Joubert

Since Specialization
Citations

This map shows the geographic impact of Jacques Joubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Joubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Joubert more than expected).

Fields of papers citing papers by Jacques Joubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Joubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Joubert. The network helps show where Jacques Joubert may publish in the future.

Co-authorship network of co-authors of Jacques Joubert

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Joubert. A scholar is included among the top collaborators of Jacques Joubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Joubert. Jacques Joubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Joubert, Jacques, et al.. (2024). NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders. Pharmaceuticals. 17(5). 639–639. 36 indexed citations
3.
Joubert, Jacques, et al.. (2023). Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022. Journal of Pharmaceutical Policy and Practice. 16(1). 34–34. 4 indexed citations
4.
Joubert, Jacques, et al.. (2022). Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA). Therapeutic Innovation & Regulatory Science. 56(5). 822–838. 2 indexed citations
5.
6.
Joubert, Jacques, et al.. (2021). Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRA. Therapeutic Innovation & Regulatory Science. 56(2). 276–290. 3 indexed citations
7.
Joubert, Jacques, Sylvester I. Omoruyi, Shireen Mentor, et al.. (2021). Multifunctional edaravone‐N‐benzyl pyridinium derivatives: AChE inhibition kinetics, in vitro neuroprotective activities and BBB permeability studies. Alzheimer s & Dementia. 17(S9). 1 indexed citations
8.
Joubert, Jacques, et al.. (2020). Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 30(9). 127075–127075. 12 indexed citations
9.
10.
Al-Wahaibi, Lamya H., Jacques Joubert, Olivier Blacque, Nora Hamad Al‐Shaalan, & Ali A. El‐Emam. (2019). Crystal structure, Hirshfeld surface analysis and DFT studies of 5-(adamantan-1-yl)-3-[(4-chlorobenzyl)sulfanyl]-4-methyl-4H-1,2,4-triazole, a potential 11β-HSD1 inhibitor. Scientific Reports. 9(1). 19745–19745. 62 indexed citations
11.
Cloete, Ruben, et al.. (2018). Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c. PLoS ONE. 13(11). e0207605–e0207605. 23 indexed citations
12.
Malan, Sarel F., et al.. (2018). Design, synthesis and evaluation of pentacycloundecane and hexacycloundecane propargylamine derivatives as multifunctional neuroprotective agents. European Journal of Medicinal Chemistry. 163. 83–94. 16 indexed citations
13.
Malan, Sarel F., et al.. (2018). Adamantane amine-linked chloroquinoline derivatives as chloroquine resistance modulating agents in Plasmodium falciparum. Bioorganic & Medicinal Chemistry Letters. 28(8). 1287–1291. 12 indexed citations
14.
15.
Joubert, Jacques, et al.. (2016). Polycyclic amines as chloroquine resistance modulating agents in Plasmodium falciparum. Bioorganic & Medicinal Chemistry Letters. 26(4). 1151–1155. 13 indexed citations
16.
Malan, Sarel F., et al.. (2015). Tricycloundecane Derivatives as Potential N‐Methyl‐D‐aspartate (NMDA) Receptor and Voltage‐Gated Calcium Channel Modulators. ChemMedChem. 10(7). 1259–1266. 7 indexed citations
17.
Joubert, Jacques, et al.. (2014). Pentacycloundecylamines and conjugates thereof as chemosensitizers and reversed chloroquine agents. Bioorganic & Medicinal Chemistry Letters. 24(23). 5516–5519. 13 indexed citations
18.
Joubert, Jacques, et al.. (2014). Polycyclic propargylamine and acetylene derivatives as multifunctional neuroprotective agents. European Journal of Medicinal Chemistry. 80. 122–134. 30 indexed citations
19.
Joubert, Jacques, et al.. (2011). Synthesis, evaluation and application of polycyclic fluorescent analogues as N-methyl-d-aspartate receptor and voltage gated calcium channel ligands. European Journal of Medicinal Chemistry. 46(10). 5010–5020. 26 indexed citations
20.
Joubert, Jacques, et al.. (2011). Synthesis and evaluation of fluorescent heterocyclic aminoadamantanes as multifunctional neuroprotective agents. Bioorganic & Medicinal Chemistry. 19(13). 3935–3944. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Guccione Breakdown of academic impact, for papers by Lesetja J. Legoabe Breakdown of academic impact, for papers by Angela Stefanachi Breakdown of academic impact, for papers by Chandra Bhushan Mishra Breakdown of academic impact, for papers by Modesto de Candia Breakdown of academic impact, for papers by Paul C. Trippier Breakdown of academic impact, for papers by Bruno Catalanotti Breakdown of academic impact, for papers by Nasimul Hoda Breakdown of academic impact, for papers by Hiroshi Kogen Breakdown of academic impact, for papers by Shikha Kumari
Rankless by CCL
2026